Contract HHSO100201500013C
Regeneron Pharmaceuticals Inc · Department Of Health And Human Services · September 1, 2015
Regeneron Pharmaceuticals Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 1, 2015 for $33.14 million of work in research and development in biotechnology. It was awarded under full and open competition. The contract has been modified 11 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 23, 2024.
Contract details
- PIID
- HHSO100201500013C
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- First action
- September 1, 2015
- Latest action
- July 23, 2024
Description
DE-OBLIGATE FISCAL YEAR 2024 CANCELING FUNDS.
Modification timeline
-
July 23, 2024Mod P00011$-1.44M
-
August 8, 2023Mod P00010REVISE THE CONTRACTING OFFICER REPRESENTATIVE, REVISE SECTION B ARTICLE B.4. ADVANCE UNDERSTANDINGS, REVISE SECTION G ARTICLE G.5. INVOICE DELIVERABLE TABLE OPT$0
-
September 23, 2022Mod P00009REGENERON- ADD HHSAR CLAUSE AT 352.232-71, ELECTRONIC SUBMISSION OF PAYMENT REQUESTS.$0
-
April 13, 2021Mod P00008REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT$0
-
November 6, 2018Mod 7REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT IGF::OT::IGF$0
-
October 24, 2017Mod 6REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT IGF::OT::IGF$0
-
May 31, 2017Mod 5REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT IGF::OT::IGF$15.09M
-
May 23, 2017Mod 4IGF::OT::IGF REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT$0
-
October 25, 2016Mod 3REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT IGF::OT::IGF$0
-
August 9, 2016Mod 2REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT IGF::OT::IGF$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201500013C?
Contract HHSO100201500013C is a federal contract awarded to Regeneron Pharmaceuticals Inc by Department Of Health And Human Services on September 1, 2015 for $33.14 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 11 times since the base award.
Who won contract HHSO100201500013C?
Regeneron Pharmaceuticals Inc won contract HHSO100201500013C from Department Of Health And Human Services.
How much is contract HHSO100201500013C worth?
Contract HHSO100201500013C has obligated $33.14 million to date, with a total potential value of $44.44 million if all options are exercised.